SCHEMBL7679489

SCHEMBL7679489

O=C(O)CC(NC(=O)OCc1ccccc1)C(=O)Cn1nnnc1Sc1ccc(OC(F)(F)F)cc1

nearest known ligand 0.45

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
GLA P06280 1/20 0.45
MAPT P10636 1/20 0.45
MAPK1 P28482 1/20 0.45
CASP1 P29466 17/20 0.45
P2RX7 Q99572 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7680033 0.90 CASP1 (0.46) CASP1
SCHEMBL7686260 0.90 CASP1 (0.54) CASP1
SCHEMBL7682003 0.89 CASP1 (0.47) CASP1
SCHEMBL7680015 0.89 CASP1 (0.43) GLAMAPTMAPK1CASP1
SCHEMBL7681198 0.88 CASP1 (0.48) CASP1
SCHEMBL7682136 0.88 CASP1 (0.48) CASP1
SCHEMBL7680006 0.88 CASP1 (0.48) CASP1
SCHEMBL7685440 0.88 CASP1 (0.48) CASP1
SCHEMBL7681865 0.87 CASP1 (0.46) CASP1
SCHEMBL7676980 0.87 CASP1 (0.54) CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6136834-A TETRAZOLE PEPTIDES ONO PHARMACEUTICAL CO., LTD. (JP) 2000-10-24 US claimed
EP-0900791-A1 TETRAZOLE DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 1999-03-10 EP claimed
US-6376484-B1 FOR PREVENTION AND/OR TREATMENT OF VARIOUS KINDS OF INFLAMMATORY DISEASE ONO PHARMACEUTICAL CO., LTD. (JP) 2002-04-23 US disclosed
US-6136834-A TETRAZOLE PEPTIDES ONO PHARMACEUTICAL CO., LTD. (JP) 2000-10-24 US disclosed
EP-0900791-A1 TETRAZOLE DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 1999-03-10 EP disclosed